Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

PROCEPT BioRobotics (PRCT) EBIAT (2020 - 2025)

PROCEPT BioRobotics has reported EBIAT over the past 6 years, most recently at -$29.8 million for Q4 2025.

  • Quarterly results put EBIAT at -$29.8 million for Q4 2025, down 58.28% from a year ago — trailing twelve months through Dec 2025 was -$95.6 million (down 4.55% YoY), and the annual figure for FY2025 was -$95.6 million, down 4.55%.
  • EBIAT for Q4 2025 was -$29.8 million at PROCEPT BioRobotics, down from -$21.4 million in the prior quarter.
  • Over the last five years, EBIAT for PRCT hit a ceiling of -$12.8 million in Q1 2021 and a floor of -$29.8 million in Q4 2025.
  • Median EBIAT over the past 5 years was -$22.0 million (2022), compared with a mean of -$22.0 million.
  • Biggest five-year swings in EBIAT: crashed 65.75% in 2023 and later surged 31.44% in 2024.
  • PROCEPT BioRobotics' EBIAT stood at -$18.3 million in 2021, then plummeted by 53.54% to -$28.2 million in 2022, then rose by 2.37% to -$27.5 million in 2023, then surged by 31.44% to -$18.9 million in 2024, then tumbled by 58.28% to -$29.8 million in 2025.
  • The last three reported values for EBIAT were -$29.8 million (Q4 2025), -$21.4 million (Q3 2025), and -$19.6 million (Q2 2025) per Business Quant data.